Organization | Lancashire Teaching Hospitals NHS Foundation Trust

Lancashire Teaching Hospitals NHS Foundation Trust Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Preston United Kingdom (2005)

Organization Overview

First Clinical Trial

2013

NCT01014858

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Lancashire Care NHS Foundation Trust | Lancashire Care Trust, Royal Blackburn Hospital

Active Ingredients

Drugs in Phase 4 Trials (9)

carbamazepine (tegretol) (1 trial)

clobazam (onfi) (1 trial)

clonazepam (klonopin) (1 trial)

ethosuximide (zarontin) (1 trial)

lacosamide (vimpat) (1 trial)

lamotrigine (lamictal) (1 trial)

levetiracetam (keppra) (1 trial)

nitrazepam (Mogadon) (1 trial)

phenytoin (mesantoin) (1 trial)

Drugs in Phase 3 Trials (1)

donepezil (aricept) (1 trial)

Drugs in Phase 2 Trials (3)

glycopyrronium (robinul) (1 trial)

minocycline (minocin) (1 trial)

scopolamine (transderm scop) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dementia (Phase 3)

Epilepsy (Phase 4)

Parkinson Disease (Phase 3)

Schizophrenia (Phase 2)

Schizophrenia Spectrum and Other Psychotic Disorders (Phase 2)

Sialorrhea (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 13